226 related articles for article (PubMed ID: 6210797)
1. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease.
Begemann M; Claas G; Falke H
Klin Wochenschr; 1982 Jan; 60(1):19-26. PubMed ID: 6210797
[TBL] [Abstract][Full Text] [Related]
2. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
[TBL] [Abstract][Full Text] [Related]
3. In vitro lymphocyte dysfunction in Hodgkin's disease.
Graze PR; Perlin E; Royston I
J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
[TBL] [Abstract][Full Text] [Related]
4. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
5. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
7. Functional activities of enriched Fc receptor bearing T lymphocytes in Hodgkin's disease.
Gulwani BN; Advani SH; Gangal SG
Oncology; 1986; 43(3):159-64. PubMed ID: 2939383
[TBL] [Abstract][Full Text] [Related]
8. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Han T; Minowada J; Subramanian V; Barcos M; Kim U
Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
[TBL] [Abstract][Full Text] [Related]
9. Autologous mixed lymphocyte reaction in man. III. Regulation of autologous MLR by theophylline-resistant and -sensitive human T-lymphocyte subpopulations.
Damle NK; Gupta S
Scand J Immunol; 1981 May; 15(5):493-9. PubMed ID: 6213031
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity of T cells to regulation by normal suppressor cells persists in long-term survivors with Hodgkin's disease.
Vanhaelen CP; Fisher RI
Am J Med; 1982 Mar; 72(3):385-90. PubMed ID: 6460444
[TBL] [Abstract][Full Text] [Related]
12. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
[TBL] [Abstract][Full Text] [Related]
13. Anti-Ia reactivity in sera of untreated patients with active Hodgkin's disease.
Romagnani S; Almerigogna F; Giudizi MG; Biagiotti R; Centis D; Alessi A; Ricci M; Tosi R
Clin Immunol Immunopathol; 1985 Jan; 34(1):1-10. PubMed ID: 3155502
[TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to normal adherent suppressor cells in untreated advanced Hodgkin's disease.
Fisher RI; Vanhaelen C; Bostick F
Blood; 1981 May; 57(5):830-5. PubMed ID: 6452184
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
[TBL] [Abstract][Full Text] [Related]
16. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
17. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Nilsson P
J Clin Lab Immunol; 1982 Jan; 7(1):51-4. PubMed ID: 6461767
[TBL] [Abstract][Full Text] [Related]
18. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
Wagener DJ; Geestman E; Borgonjen A; Haanen C
Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
[TBL] [Abstract][Full Text] [Related]
19. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.
Björkholm M; Holm G; Mellstedt H; Pettersson D
Clin Exp Immunol; 1975 Dec; 22(3):373-7. PubMed ID: 131665
[TBL] [Abstract][Full Text] [Related]
20. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
Fuks Z; Strober S; Kaplan HS
N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
